rs1052717
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004599.4(SREBF2):c.2208+414A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.623 in 152,174 control chromosomes in the GnomAD database, including 31,372 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004599.4 intron
Scores
Clinical Significance
Conservation
Publications
- neurocutaneous syndromeInheritance: AD Classification: MODERATE Submitted by: PanelApp Australia
- multiple congenital anomalies/dysmorphic syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary spastic paraplegiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004599.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.622 AC: 94646AN: 152056Hom.: 31312 Cov.: 33 show subpopulations
GnomAD4 genome AF: 0.623 AC: 94760AN: 152174Hom.: 31372 Cov.: 33 AF XY: 0.620 AC XY: 46134AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at